Impact of concomitant acid suppressive therapy on pazopanib efficacy and dose reductions in patients with metastatic renal cell carcinoma.
Eur J Clin Pharmacol
; 76(9): 1273-1280, 2020 Sep.
Article
in En
| MEDLINE
| ID: mdl-32474662
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Pyrimidines
/
Sulfonamides
/
Carcinoma, Renal Cell
/
Proton Pump Inhibitors
/
Histamine H2 Antagonists
/
Kidney Neoplasms
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur J Clin Pharmacol
Year:
2020
Type:
Article
Affiliation country:
Belgium